VRTX
Vertex Pharmaceuticals Incorporated
Revenue to net incomeLast 12 months
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $13.0B | +14.1% |
| Gross profit | $11.1B | +13.6% |
| Operating income | $4.3B | +7.9% |
| Net income | $4.0B | +7.8% |
| EPS | $15.54 | +8.3% |
| Free cash flow | $3.2B | +1.3% |